Millions of blood tubes have been secured by the United Kingdom following the warning of shortages.
The British Medical Association (BMA) said Hospital-wide shortages and general practitioner surgery were “serious” If the NHS does not reduce usage, “even the most clinically important blood tests can be at risk.”
On Tuesday, it was announced that medical technology company Becton Dickinson (BD) had received an “exceptional license” to import blood tubes.
The tube is approved for use in other countries, including the United States.
A spokesperson for the Ministry of Health said: “We have secured tens of millions of additional blood tubes, including imports of additional supplies from the EU and the United States. We will continue clinically urgent testing.
“Patient safety has always been a top priority and we continue to work closely with the NHS England, delegated authorities, and the NHS to minimize its impact on patient care.”
This week, 9 million additional tubes were supplied to the NHS for “immediate distribution,” and BD completed improvements to its UK manufacturing facility, which “increased capacity by 20%” to reduce order backlog. I said I did.
The NHS England issued guidance in the face of a global shortage, and Dr. David Wrigley, Vice-Chair of the BMA Council, called the situation a “crisis” and put doctors in a “terrible, enviable position.”
On August 26, the NHS boss warned the GP and hospital trusts that “supply is expected to be further restricted in the coming weeks.”
Except for “clinically urgent” tests, all primary care and community tests must be suspended until September 17.
Acute and mental health trusts were also told to reduce their demand by at least 25% during that period.
UK secures millions of blood tubes in the threat of shortage | UK News
SourceUK secures millions of blood tubes in the threat of shortage | UK News